Long-term outcomes of survivors of neonatal insults: A systematic review and meta-analysis

Abstract

Background

The Millennium Developmental Goals ensured a significant reduction in childhood mortality. However, this reduction simultaneously raised concerns about the long-term outcomes of survivors of early childhood insults. This systematic review focuses on the long-term neurocognitive and mental health outcomes of neonatal insults (NNI) survivors who are six years or older.

Methods

Two independent reviewers conducted a comprehensive search for empirical literature by combining index and free terms from the inception of the databases until 10th October 2019. We also searched for additional relevant literature from grey literature and using reference tracking. Studies were included if they: were empirical studies conducted in humans; the study participants were followed at six years of age or longer; have an explicit diagnosis of NNI, and explicitly define the outcome and impairment. Medians and interquartile range (IQR) of the proportions of survivors of the different NNI with any impairment were calculated. A random-effect model was used to explore the estimates accounted for by each impairment domain.

Results

Fifty-two studies with 94,978 participants who survived NNI were included in this systematic review. The overall prevalence of impairment in the survivors of NNI was 10.0% (95% CI 9.8–10.2). The highest prevalence of impairment was accounted for by congenital rubella (38.8%: 95% CI 18.8–60.9), congenital cytomegalovirus (23.6%: 95% CI 9.5–41.5), and hypoxic-ischemic encephalopathy (23.3%: 95% CI 14.7–33.1) while neonatal jaundice has the lowest proportion (8.6%: 95% CI 2.7–17.3). The most affected domain was the neurodevelopmental domain (16.6%: 95% CI 13.6–19.8). The frequency of impairment was highest for neurodevelopmental impairment [22.0% (IQR = 9.2–24.8)] and least for school problems [0.0% (IQR = 0.0–0.00)] in any of the conditions.

Conclusion

The long-term impact of NNI is also experienced in survivors of NNI who are 6 years or older, with impairments mostly experienced in the neurodevelopmental domain. However, there are limited studies on long-term outcomes of NNI in sub-Saharan Africa despite the high burden of NNI in the region.

Trial registration

Registration number: CRD42018082119.

About the Authors:

Dorcas N. Magai

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

* E-mail: [email protected]

Affiliations Centre for Geographic Medicine Research Coast, Kenya Medical Research Institute, Kilifi, Kenya, Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, The Netherlands

ORCID logo http://orcid.org/0000-0002-1889-7552

Eirini Karyotaki

Roles Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – review & editing

Affiliation: Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, The Netherlands

ORCID logo http://orcid.org/0000-0002-0071-2599

Agnes M. Mutua

Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing

Affiliation: Centre for Geographic Medicine Research Coast, Kenya Medical Research Institute, Kilifi, Kenya

ORCID logo http://orcid.org/0000-0002-0072-0839

Esther Chongwo

Roles Data curation, Formal analysis, Investigation, Methodology, Software, Writing – review & editing

Affiliation: Centre for Geographic Medicine Research Coast, Kenya Medical Research Institute, Kilifi, Kenya

Carophine Nasambu

Roles Conceptualization, Data curation, Methodology, Resources, Software, Validation, Visualization, Writing – review & editing

Affiliation: Centre for Geographic Medicine Research Coast, Kenya Medical Research Institute, Kilifi, Kenya

Derrick Ssewanyana

Roles Conceptualization, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – review & editing

Affiliations Centre for Geographic Medicine Research Coast, Kenya Medical Research Institute, Kilifi, Kenya, Utrecht Centre for Child and Adolescent Studies, Utrecht University, Utrecht, The Netherlands

ORCID logo http://orcid.org/0000-0002-7848-7643

Charles R. Newton

Roles Conceptualization, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing

Affiliations Centre for Geographic Medicine Research Coast, Kenya Medical Research Institute, Kilifi, Kenya, Department of Public Health, Pwani University, Kilifi, Kenya, Department of Psychiatry, University of Oxford, Oxford, England, United Kingdom

Hans M. Koot

Roles Formal analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing – review & editing

Affiliation: Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, The Netherlands

ORCID logo http://orcid.org/0000-0002-9643-2363

Amina Abubakar

Roles Conceptualization, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing

Affiliations Centre for Geographic Medicine Research Coast, Kenya Medical Research Institute, Kilifi, Kenya, Department of Public Health, Pwani University, Kilifi, Kenya, Department of Psychiatry, University of Oxford, Oxford, England, United Kingdom, Institute for Human Development, Aga Khan University, Nairobi, Kenya

ORCID logo http://orcid.org/0000-0002-3686-7904

Introduction

Neonatal insults (NNI), defined as injury during the first 28 days of life, are associated with neonatal mortality, morbidity, and adverse neurodevelopmental outcome [1]. Globally, 5.9 million child deaths occur annually during the perinatal and neonatal periods [2, 3], accounting for 43% of deaths in children younger than 5 years of age [4]. Out of the total child-deaths that occur during this period, almost three-quarters occur in sub-Saharan Africa (SSA) and South Asia [5]. As part of the Millennium Developmental Goals, there was a global commitment to reduce childhood mortality by two-thirds between 1990 to 2015 [6]. Although the target was not fully achieved, there was a significant reduction in annual childhood mortality from 12.7 million in 1990 to 5.7 million in 2015 [7]. This reduction has increased attention about the long-term outcomes that may affect the functioning and quality of life of those children who survived early childhood conditions, and especially NNI (5).

Globally, the most common NNI include sepsis, congenital meningitis, hypoxic-ischemic encephalopathy (HIE), preterm birth, neonatal jaundice (NNJ), cytomegalovirus infection (CMV), herpes, congenital rubella, and toxoplasmosis [8]. Children who survive NNI are likely to develop adverse long-term outcomes such as neurocognitive impairment, developmental delay, hearing and visual impairment, cerebral palsy, and behavioral and emotional problems [9–15]. For instance, children who survived CMV were reported to develop sensorineural hearing loss and neurodevelopmental impairment [9], while congenital rubella is associated with hearing impairment [16, 17]. Intrauterine growth restriction (IUGR) is associated with neurodevelopmental impairment in the early years [12]; HIE was associated with motor and developmental delay during infancy [10], and NNJ was associated with adverse neurodevelopmental outcomes [8, 18–22].

There are few systematic reviews on the long-term outcomes of NNI. A review by Mwaniki et al. [8] included 153 studies with 22161 survivors of intrauterine insults with a follow-up period of at least 6 months and found that 39% of children who survive intrauterine or neonatal insults develop at least one long-term sequelae. The authors found that the survivors are likely to develop neurocognitive problems (cognitive impairment, developmental delays, and learning difficulties), visual and hearing impairment, and cerebral palsy. Mwaniki and colleagues also reported that congenital rubella and HIE had the highest prevalence of long-term sequelae (37% and 81% respectively) while NNJ has the lowest risk for long-term sequelae (18%).

Mwaniki et al.’s study reviewed studies with both short-term and long-term outcomes (from 6-months-old infants and older children); however, less is known about the long-term outcomes in school-aged children or older age groups globally who survived NNI [8]. As children grow older, their brains may compensate for brain injury during the neonatal period–a phenomenon termed brain plasticity [23]. Therefore NNI-associated impairments reported during early childhood may resolve as children grow older; it is, therefore, essential to identify on the residual neurodevelopmental sequelae at school-age and older age, which may persist and interfere with education, employment, and social functioning. This systematic review focuses on the long-term neurocognitive and mental health outcomes of NNI survivors who are six years or older.

Methods

Literature search

We conducted a comprehensive search for empirical literature in the following databases: PubMed, PsycINFO, Web of Science, Embase, and CINHAL. Relevant grey literature was searched in: ERIC, Open Grey, The Health Care Management Information Consortium (HMIC) database, the National Technical Information Service, and PsycEXTRA. We also used reference tracking to search for additional relevant literature. The detailed search terms (formulated by DNM and AA) comprised the index, and free terms of the different neonatal insults and the outcome measures combined with Boolean operators (“OR” and “AND”) were used each database (S1 Appendix). The literature search included studies conducted from 1947 to 10th October 2019. This systematic review is registered in PROSPERO (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=82119); registration number CRD42018082119.

Inclusion and exclusion criteria

Four reviewers (DNM, CN, EC, and AMM) independently screened the articles by titles, abstract, and full text for eligibility. Criteria for eligible studies were: i) empirical studies conducted in humans; ii) the study participants had follow-up data coinciding with the age bracket at 6 years or older (we considered children from six years as this is the age where most children join elementary school, especially in low-and-middle-income countries); iii) explicit diagnostic criteria for the neonatal insult, and iv) precise definition of the outcome and impairment (based on either a comparison to a control or a standardized test). Studies were excluded if i) it was not clear if the children had the diagnosis of NNI during the neonatal period (i.e., the first 28 days of life); ii) participants had another comorbid neural tube defect conditions, e.g. spina bifida; and iii) if the studies did not make a comparison to either a control or standardized test to define impairment in the outcomes.

Data extraction and quality assessment

Information extracted from the studies included: the author’s name and year of publication, the country where the study was conducted, the sample size, age of participants at follow-up, study design, the type of neonatal insult, the assessment tools used, the neurocognitive or mental health outcome assessed, and a general summary of the study findings (see S1 Table). Quality assessment of the studies in this review was guided by the Newcastle-Ottawa scale (NOS) for assessment of the quality of cohort studies [24]. This quality assessment tool assigns a maximum of four points for selection, two points for comparability, and three points for exposure or outcome. The ranking of the total scores is as follows: 0–3 for low-quality studies, 4–6 for moderate quality, and 7–9 for high-quality studies. Both data extraction and quality assessment of the studies were independently done by two reviewers (DNM and AMM). In cases where the reviewers disagreed on articles included, disagreements were resolved by reassessment of the studies, discussions, and a third reviewer where necessary.

Data analysis

Descriptive statistics such as frequencies and percentages were used to describe the outcomes in different impairment domains for each neonatal insult, the geographic distribution of studies, and the NNI reported. Medians and interquartile range (IQR) of the proportions of survivors of the different NNI with any impairment were calculated.

The outcome variable was categorized into 6 major domains of impairment: i) neurodevelopmental impairment (cognition, language, developmental delay, memory); ii) hearing impairment; iii) vision impairment; iv) neurological impairment (cerebral palsy, clinical, and motor impairment); v) epilepsy; and vi) mental/behavioral problems. The criteria for the outcomes assessed and instruments used are provided in S1 Table. The variation in effect sizes attributed to heterogeneity was explored using I2 statistic of the DerSimonian and Laird method [25]. The 95% confidence interval (95% CI) around the I2 was used to express the uncertainty associated with the I2. A random-effect model was then used—after Freeman-Turkey Double Arcsine transformation—to explore the estimates accounted for by each impairment domain. Impairment domains represented by less than 3 studies per condition were excluded from this analysis. Data were analyzed using STATA (version 15) [26].

To explore the confounding effects of follow-up periods (6–12 years, 13–18 years, and >18 years), study design (prospective vs retrospective), and region (North America, Asia, Europe, and Oceania) on the risk of impairment, a meta-regression was conducted for preterm birth only as other conditions had less than ten studies. To identify extreme findings, a visual inspection of the funnel plot was done, and Begg’s adjusted rank correlation explored.

Results

Fifty-two eligible studies (S1 Appendix) were included in this systematic review following a screening process that involved 80,038 articles (see Fig 1). Of the 52 eligible studies, 44.2% had an unexposed comparison group, while 55.8% only included an exposed group. For studies that had control groups, we report only on the case group (i.e. children who were diagnosed with NNI). More than half of the eligible studies were conducted in Europe (59.6%), 26.9% were conducted in North America, 7.7% were conducted in Asia, 5.8% were conducted in Oceania countries, and none in Africa. Most of the studies (76.9%) had a prospective study design, while 23.1% used a retrospective study design. A table with a summary of the characteristics of the studies is provided in S1 Table. The quality assessment of the 52 eligible studies indicates that 30 studies (57.7%) were categorized as “medium” quality while 22 studies (42.3%) were categorized as “high” quality (see S2 Table).

[Figure omitted. See PDF.]

Fig 1. Flow chart showing the selection of studies on long-term outcomes of neonatal insults.

https://doi.org/10.1371/journal.pone.0231947.g001

Overall, 94,978 survivors of NNI were included in the studies in this review. The median number of participants per study was 125 (IQR = 78.5–281.5). The median age at follow-up was 8 years (6.0 to 10.0) years. The proportion of impairment among study participants aggregated by the form of NNI is summarized in Table 1. The most examined or studied NNI were HIE (15.4%), NNJ (15.4%), and preterm birth (42.3%). The overall prevalence of impairment in the survivors of NNI was 10.0% (95% CI 9.8–10.2). The highest prevalence of impairment was accounted for by congenital rubella (38.8%: 95% CI 18.8–60.9), CMV (23.6%: 95% CI 9.5–41.5), and HIE (23.3%: 95% CI 14.7–33.1) while NNJ has the lowest proportion (8.6%: 95% CI 2.7–17.3). The most affected domain was the neurodevelopmental domain (16.6%: 95% CI 13.6–19.8). The frequency of impairment was highest for neurodevelopmental impairment [22.0% (IQR = 9.2–24.8)] and least for school problems [0.0% (IQR = 0.0–0.00)] in any of the conditions (Table 2).

[Figure omitted. See PDF.]

Table 1. Summary of Proportion of Impairment in Survivors of Neonatal Insults.

https://doi.org/10.1371/journal.pone.0231947.t001

[Figure omitted. See PDF.]

Table 2. Medians and Interquartile Range (IQR) of the Proportions of Impairment in Survivors of Neonatal Insults.

https://doi.org/10.1371/journal.pone.0231947.t002

In this meta-analysis, the highest prevalence of neurodevelopmental impairment was accounted for by HIE (31.6%: 95% CI 19.6–45.0) (Fig 2) and preterm birth (25.2%: 95% CI 15.1–36.8) (Fig 3). The prevalence of neurodevelopmental impairment in NNJ was 10.3% (95% CI 2.2–23.2) (Fig 4). Hearing impairment was most prevalent in congenital rubella (78.6: 95%CI 16.4–100.0) (Fig 5), while visual impairment was common in preterm birth (27.6%: 95% CI 20.6–35.2) (Fig 3). We conducted a subgroup analysis of 15 preterm birth studies with extremely low birth weight participants, and similar results were obtained. The least affected domains were mental health problems for fetal growth restriction (17.1%: 95% CI 12.6–22.2) (Fig 6) and neurological impairment in preterm birth (11.1%: 95% CI 6.1–17.2) (Fig 5). The meta-analysis was not possible for CMV due to the limited number of studies.

[Figure omitted. See PDF.]

Fig 2. Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of fetal growth restriction.

I2- heterogeneity statistic; ES- effect size; %—percent; sub-groups with (I2 = . %, p = .) indicate that the number of studies were too few for the estimates to be calculated.

https://doi.org/10.1371/journal.pone.0231947.g002

[Figure omitted. See PDF.]

Fig 3. Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Preterm Birth.

I2- heterogeneity statistic; ES- effect size; %—percent; sub-groups with (I2 = . %, p = .) indicate that the number of studies were limited for the estimates to be calculated.

https://doi.org/10.1371/journal.pone.0231947.g003

[Figure omitted. See PDF.]

Fig 4. Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Neonatal Jaundice.

https://doi.org/10.1371/journal.pone.0231947.g004

[Figure omitted. See PDF.]

Fig 5. Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Congenital Rubella.

I2- heterogeneity statistic; ES- effect size; %—percent; sub-groups with (I2 = . %, p = .) indicate that the number of studies were limited for the estimates to be calculated.

https://doi.org/10.1371/journal.pone.0231947.g005

[Figure omitted. See PDF.]

Fig 6. Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Hypoxic-ischemic encephalopathy.

https://doi.org/10.1371/journal.pone.0231947.g006

We did not find any statistically significant results from the meta-regression of the pooled proportion of impairment in preterm birth when the predictive factors of age at follow-up, region, and study design were included in the model. The funnel plot indicated an asymmetric plot confirming publication bias. The studies also had high heterogeneity which explains the asymmetry observed in the funnel plots.

Discussion

This systematic review identified 52 studies that evaluated the long-term outcomes of NNI in school-aged children and older groups. Despite the limited data in these age groups, our study found 10% overall prevalence of impairment in survivors of NNI at age 6 years and above. The neurodevelopmental domain was the most commonly affected. Congenital rubella and HIE accounted for the highest frequency of impairment, while NNJ accounted for the least impairment.

Our findings that the neurodevelopmental domain is the most affected are similar to the results by Mwaniki and colleagues [8], however, the frequency was higher in their study (59% compared to 16.6% in the present study), and their samples comprised younger age-groups. These differences potentially demonstrate that neurodevelopmental impairment diminishes with age in most survivors due to the plasticity of the brain [8]. Another plausible reason may be that children with severe neurodevelopmental impairment did not survive to older age, thereby leading to a diminished proportion observed in older ages. It is also likely that the burden of neurodevelopmental impairment in low and middle-income resource settings like SSA may not be well represented by existing research. Moreover, not all the studies in this current review have reported on all domains of impairment; it is possible that the burden in certain domains is underestimated. There is a need for more comprehensive longitudinal studies from SSA to better characterize the impact of NNI.

Similar to the results by Mwaniki and colleagues [8], congenital rubella and HIE were associated with the most frequent adverse long-term outcomes. A possible explanation regards to the pathogenesis of these conditions. Congenital rubella, affects the systemic organs of neonates [77] and causes cell and tissue damage, and is associated with ocular, heart, and hearing impairment. In individuals affected by HIE, the blood circulation or blood flow to the brain is impaired, leading to decreased oxygen and energy to the brain. This decrease in oxygen and energy can result in brain cell death and additional scar to the white matter or neuronal cell death in severe hypoxia [78], which may result in irreversible brain damage.

Although three-quarters of child deaths occur in SSA and South Asia, many of which are related to NNI, studies in Africa that examine the long-term outcome of NNI are scarce, and none was included in this review. The lack of research in these age groups could be attributed to the lack of appropriate assessment tools, inadequate access to health-care, or lack of research expertise in this area. This is unfortunate and has serious implications as school-aged children, or older age groups who survived NNI, but live with some degree of impairment may not receive the needed care and attention. Therefore, their potential outcomes are not fully optimized; hence, they may miss required support, such as getting specialized education and continue to be marginalized.

The major strengths of this study are the use of multiple databases and a focus on long-term outcomes that are often not well studied. Additionally, the study utilized a rigorous study design for systematic reviews and meta-analysis. Lastly, the study focuses on a global perspective and further sub-categorizes the domains of impairment, making it comprehensive.

However, this study has several limitations. First, the study inclusion criteria were strict and may have omitted some studies that could be included, e.g. studies that did not include a confirmed diagnosis in the first 28 days of life (e.g., vertical HIV infection). Second, the inclusion of all children with a diagnosis of NNJ or HIE in the study without considering the severity levels might have diluted our sample.

Third, in this review, a few studies reported multi-domain impairments in the patients. For instance, many participants with cerebral palsy will also have motor impairment and learning difficulties, which we found complex to conduct subgroup analysis. Fourth, the studies included were highly heterogeneous. However, we used the random effect model, which accounted for unexplained heterogeneity observed in the studies [79]. Lastly, the results of this study should be cautiously interpreted as we found publication bias indicated by the asymmetric forest plot, which may imply that studies with statistically significant results were more likely to be published than those with non-significant results. The publication bias could also reflect the high heterogeneity in the studies included in this systematic review and meta-analysis.

These results have several implications for research and prevention strategies. The review identifies that various forms of NNI have several adverse long-term outcomes, which necessitates further management and close monitoring of survivors of NNI. Despite the improvements in neonatal care and management of birth complications to prevent child mortality, there is still need for treatment and improved care for child survivors of NNI to protect the central nervous system and prevent adverse long-term outcomes. More resources should be allocated for longer follow-ups of survivors of NNI and preventive and rehabilitative services provided to them to optimize their outcomes. Long-term follow-up research is also needed to better understand the outcomes of NNI, especially in SSA where there is a high burden of NNI, and proper medical care is limited.

Conclusion

NNI have long-term consequences that are experienced far beyond early childhood to older ages. The major impairments arising from NNI are recorded in the neurodevelopmental domains (cognition, language, developmental delay, and memory). However, this finding is based on studies from high-income countries such as Europe and America with the state of art of care for children. There are no robust studies on long-term outcomes of NNI in SSA despite the high burden of NNI in this region. Therefore, more investment of longer follow-ups of survivors of NNI is needed in SSA to optimize their outcomes fully.

Supporting information

[Figure omitted. See PDF.]

S1 Checklist. PRISMA 2009 checklist.

https://doi.org/10.1371/journal.pone.0231947.s001

(DOC)

S1 Appendix. Search terms.

https://doi.org/10.1371/journal.pone.0231947.s002

(DOCX)

S2 Appendix. References of studies included in the review.

https://doi.org/10.1371/journal.pone.0231947.s003

(DOCX)

S1 Table. Characteristics of studies included in the review.

https://doi.org/10.1371/journal.pone.0231947.s004

(DOCX)

S2 Table. Assessment of quality of studies.

https://doi.org/10.1371/journal.pone.0231947.s005

(XLSX)

Acknowledgments

We acknowledge permission from the Director of Kenya Medical Research Institute (KEMRI) to publish this work.

Citation: Magai DN, Karyotaki E, Mutua AM, Chongwo E, Nasambu C, Ssewanyana D, et al. (2020) Long-term outcomes of survivors of neonatal insults: A systematic review and meta-analysis. PLoS ONE 15(4): e0231947. https://doi.org/10.1371/journal.pone.0231947

References

1. Gordon AL, English M, Tumaini Dzombo J, Karisa M, Newton CR. Neurological and developmental outcome of neonatal jaundice and sepsis in rural Kenya. Tropical Medicine & International Health. 2005;10(11):1114–20. pmid:16262736

2. Haider BA, Bhutta ZA. Birth asphyxia in developing countries: current status and public health implications. Current Problems in Pediatric and Adolescent Health Care. 2006;5(36):178–88. pmid:16631096

3. Padayachee N, Ballot DE. Outcomes of neonates with perinatal asphyxia at a tertiary academic hospital in Johannesburg, South Africa. South African Journal of Child Health. 2013;7(3):89–94.

4. You D, Wardlaw T, Salama P, Jones G. Levels and trends in under-5 mortality, 1990–2008. The Lancet. 2010;375(9709):100–103.

5. Joy E lawn CS, Zulfiqar Bhutta A, Gary Darmstadt L, Jose Martines, Vinod Paul, Rudolf Knippenberg. Why are 4 million newborn babies dying each year? Lancet. 2004;364:399–401. pmid:15288723

6. Sachs JD, McArthur JW. The millennium project: a plan for meeting the millennium development goals. The Lancet. 2005;365(9456):347–353.

7. Rajaratnam JK, Marcus JR, Flaxman AD, Wang H, Levin-Rector A, Dwyer L, et al. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970–2010: a systematic analysis of progress towards Millennium Development Goal 4. The Lancet. 2010;375(9730):1988–2008.

8. Mwaniki MK, Atieno M, Lawn JE, Newton CR. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. The Lancet. 2012;379(9814):445–452.d oi: pmid:22244654

9. Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P. Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic review. Reviews in Medical Virology. 2017;27(5).

10. Conway J, Walsh B, Boylan G, Murray D. Mild hypoxic ischaemic encephalopathy and long term neurodevelopmental outcome-A systematic review. Early Human Development. 2018;120:80–87. pmid:29496329

11. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2010;10(5):317–328. pmid:20417414

12. Levine TA, Grunau RE, McAuliffe FM, Pinnamaneni R, Foran A, Alderdice FA. Early childhood neurodevelopment after intrauterine growth restriction: a systematic review. Pediatrics. 2014;135(1) 126–141. pmid:25548332

13. Lopez AL, Raguindin PF, Del Rosario JJ, Najarro RV, Du E, Aldaba J, et al. The burden of congenital rubella syndrome in the Philippines: results from a retrospective assessment. Western Pacific Surveillance and Response Journal: WPSAR. 2017;8(2). pmid:29184700

14. McGuire W. Perinatal asphyxia. BMJ Clinical Evidence. 2007:15(511).

15. Slusher TM, Zamora TG, Appiah D, Stanke JU, Strand MA, Lee BW, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatrics Open. 2017;1(1). pmid:29637134

16. McIntosh E, Menser M. A fifty-year follow-up of congenital rubella. The Lancet. 1992;340(8816):414–5.

17. Menser M, Dods L, Harley J. A twenty-five-year follow-up of congenital rubella. The Lancet. 1967;290(7530):1347–50.

18. Ogunlesi T, Dedeke I, Adekanmbi A, Fetuga M, Ogunfowora O. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria. 2007;16(4):354–9.

19. Olusanya B, Akande A, Emokpae A, Olowe S. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Tropical Medicine & International Health. 2009;14(3):301–10. pmid:19187520

20. Owa J, Dawodu A. Neonatal jaundice among Nigerian preterm infants. West African Journal of Medicine. 1990;9(4):252–7. pmid:2083201

21. Wolf M, Beunen G, Casaer P, Wolf B. Extreme hyperbilirubinaemia in Zimbabwean neonates: neurodevelopmental outcome at 4 months. European Journal of Pediatrics. 1997;156(10):803–7. pmid:9365074

22. Wolf M-J, Wolf B, Beunen G, Casaer P. Neurodevelopmental outcome at 1 year in Zimbabwean neonates with extreme hyperbilirubinaemia. European Journal of Pediatrics. 1999;158(2):111–4. pmid:10048606

23. Kolb B, Gibb R. Searching for the principles of brain plasticity and behavior. Cortex. 2014;58:251–60. pmid:24457097

24. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute; 2009. Available in March. 2016.

25. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemporary Clinical Trials. 2007;28(2):105–14. pmid:16807131

26. StataCorp L. Stata statistical software, version 11. StataCorp College Station (TX): StataCorp LP. 2009.

27. Stevens J, Eames M, Kent A, Halket S, Holt D, Harvey D. Long term outcome of neonatal meningitis. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2003;88(3):F179–F84. pmid:12719389

28. Ishikawa T, Ogawa Y, Kanayama M, Wada Y. Long-term prognosis of asphyxiated full-term neonates with CNS complications. Brain and Development. 1987;9(1):48–53. pmid:3605539

29. Korndewal MJ, Oudesluys‐Murphy AM, Kroes AC, Van der Sande MA, De Melker HE, Vossen AC. Long‐term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study. Developmental Medicine & Child Neurology. 2017;59(12):1261–8. pmid:28990181

30. Lanzieri TM, Chung W, Flores M, Blum P, Caviness AC, Bialek SR, et al. Hearing loss in children with asymptomatic congenital cytomegalovirus infection. Pediatrics. 2017;139(3):e20162610. pmid:28209771

31. Zhang X-W, Li F, Yu X-W, Shi X-W, Shi J, Zhang J-P. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. Journal of Clinical Virology. 2007;40(3):180–5. pmid:17919973

32. Anvar B, Mencher GT, Keet SJ. Hearing loss and congenital rubella in Atlantic Canada. Ear and Hearing. 1984;5(6):340–5. pmid:6510579

33. Chess S, Fernandez P, Korn S. Behavioral consequences of congenital rubella. The Journal of Pediatrics. 1978;93(4):699–703. pmid:702254

34. Desmond MM, Fisher ES, Vorderman AL, Schaffer HG, Andrew LP, Zion TE, et al. The longitudinal course of congenital rubellaencephalitis in nonretarded children. The Journal of Pediatrics. 1978;93(4):584–91. pmid:81297

35. Beukers F, Aarnoudse-Moens CS, van Weissenbruch MM, Ganzevoort W, van Goudoever JB, van Wassenaer-Leemhuis AG. Fetal growth restriction with brain sparing: neurocognitive and behavioral outcomes at 12 years of age. The Journal of Pediatrics. 2017;188:103–9. pmid:28693788

36. Guellec I, Lapillonne A, Marret S, Picaud J-C, Mitanchez D, Charkaluk M-L, et al. Effect of intra-and extrauterine growth on long-term neurologic outcomes of very preterm infants. The Journal of Pediatrics. 2016;175:93–9. pmid:27318373

37. Guellec I, Lapillonne A, Renolleau S, Charlaluk M-L, Roze J-C, Marret S, et al. Neurologic outcomes at school age in very preterm infants born with severe or mild growth restriction. Pediatrics. 2011;127(4): 883–91. pmid:21382951

38. Leitner Y, Fattal-Valevski A, Geva R, Eshel R, Toledano-Alhadef H, Rotstein M, et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. Journal of Child Neurology. 2007;22(5):580–7. pmid:17690065

39. Barnett A, Mercuri E, Rutherford M, Haataja L, Frisone M, Henderson S, et al. Neurological and perceptual-motor outcome at 5–6 years of age in children with neonatal encephalopathy: relationship with neonatal brain MRI. Neuropediatrics. 2002;33(05):242–8.

40. Lindström K, Lindblad F, Hjern A. Preterm birth and attention-deficit/hyperactivity disorder in schoolchildren. Pediatrics. 2011;127(5):858–65. pmid:21502231

41. Marlow N, Rose A, Rands C, Draper E. Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2005;90(5):F380–F7. pmid:16113154

42. Natarajan G, Shankaran S, Pappas A, Bann C, Tyson JE, McDonald S, et al. Functional status at 18 months of age as a predictor of childhood disability after neonatal hypoxic‐ischemic encephalopathy. Developmental Medicine & Child Neurology. 2014;56(11):1052–8. pmid:24957482

43. Pappas A, Shankaran S, McDonald SA, Vohr BR, Hintz SR, Ehrenkranz RA, et al. Cognitive outcomes after neonatal encephalopathy. Pediatrics. 2015;135(3):e624–e34. pmid:25713280

44. van Handel M, Swaab H, de Vries LS, Jongmans MJ. Behavioral outcome in children with a history of neonatal encephalopathy following perinatal asphyxia. Journal of Pediatric Psychology. 2009;35(3):286–95. pmid:19542199

45. van Kooij BJ, van Handel M, Nievelstein RA, Groenendaal F, Jongmans MJ, de Vries LS. Serial MRI and neurodevelopmental outcome in 9-to 10-year-old children with neonatal encephalopathy. The Journal of Pediatrics. 2010;157(2):221–7. pmid:20381069

46. van Schie PE, Schijns J, Becher JG, Barkhof F, van Weissenbruch MM, Vermeulen RJ. Long-term motor and behavioral outcome after perinatal hypoxic-ischemic encephalopathy. European Journal of Paediatric Neurology. 2015;19(3):354–9. pmid:25683783

47. Boskabadi H, Maamouri G, Mafinejad S, Rezagholizadeh F. Clinical course and prognosis of hemolytic jaundice in neonates in North East of Iran. Macedonian Journal of Medical Sciences. 2011;4(4):403–7.

48. Chen M-H, Su T-P, Chen Y-S, Hsu J-W, Huang K-L, Chang W-H, et al. Is neonatal jaundice associated with autism spectrum disorder, attention deficit hyperactivity disorder, and other psychological development? A nationwide prospective study. Research in Autism Spectrum Disorders. 2014;8(6):625–32.

49. Culley P, Powell J, Waterhouse J, Wood B. Sequelae of neonatal jaundice. Br Med J. 1970;3(5719):383–6. pmid:5451590

50. Hokkanen L, Launes J, Michelsson K. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates—a 30 year prospective follow-up study. PeerJ. 2014;2:e294. pmid:24688870

51. Kuzniewicz M, Newman TB. Interaction of hemolysis and hyperbilirubinemia on neurodevelopmental outcomes in the collaborative perinatal project. Pediatrics. 2009;123(3):1045–50. pmid:19255038

52. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics. 1993;92(5):651–7. pmid:8414851

53. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics. 1991;88(4):828–33. pmid:1896294

54. Vandborg PK, Hansen BM, Greisen G, Mathiasen R, Kasper F, Ebbesen F. Follow‐up of extreme neonatal hyperbilirubinaemia in 5‐to 10‐year‐old children: a Danish population‐based study. Developmental Medicine & Child Neurology. 2015;57(4):378–84. pmid:25353277

55. Anderson PJ, Treyvaud K, Neil JJ, Cheong JL, Hunt RW, Thompson DK, et al. Associations of newborn brain magnetic resonance imaging with long-term neurodevelopmental impairments in very preterm children. The Journal of Pediatrics. 2017;187:58–65. pmid:28583705

56. Andrews WW, Cliver SP, Biasini F, Peralta-Carcelen AM, Rector R, Alriksson-Schmidt AI, et al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. American Journal of Obstetrics and Gynecology. 2008;198(4):466. pmid:18395043

57. Bora S, Pritchard VE, Moor S, Austin NC, Woodward LJ. Emotional and behavioural adjustment of children born very preterm at early school age. Journal of Paediatrics and Child Health. 2011;47(12):863–9. pmid:21679332

58. Bos AF, Roze E. Neurodevelopmental outcome in preterm infants. Developmental Medicine & Child Neurology. 2011;53:35–9. pmid:18317268

59. Brévaut-Malaty V, Busuttil M, Einaudi M-A, Monnier A-S, D’Ercole C, Gire C. Longitudinal follow-up of a cohort of 350 singleton infants born at less than 32 weeks of amenorrhea: neurocognitive screening, academic outcome, and perinatal factors. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010;150(1):13–8. pmid:20106582

60. Dotinga BM, de Winter AF, Bocca-Tjeertes IF, Kerstjens JM, Reijneveld SA, Bos AF. Longitudinal growth and emotional and behavioral problems at age 7 in moderate and late preterms. PLOS ONE. 2019;14(1):e0211427. pmid:30703154

61. Easson K, Dahan-Oliel N, Rohlicek C, Sahakian S, Brossard-Racine M, Mazer B, et al. A Comparison of Developmental Outcomes of Adolescent Neonatal Intensive Care Unit Survivors Born with a Congenital Heart Defect or Born Preterm. The Journal of Pediatrics. 2019;207:34–41. e2. pmid:30528759

62. Foulder-Hughes L, Cooke R. Motor, cognitive, and behavioural disorders in children born very preterm. Developmental Medicine and Child Neurology. 2003;45(2):97–103. pmid:12578235

63. Geldof CJ, van Hus JW, Jeukens-Visser M, Nollet F, Kok JH, Oosterlaan J, et al. Deficits in vision and visual attention associated with motor performance of very preterm/very low birth weight children. Research in Developmental Disabilities. 2016;53:258–66. pmid:26950510

64. Geldof CJ, van Wassenaer-Leemhuis AG, Dik M, Kok JH, Oosterlaan J. A functional approach to cerebral visual impairments in very preterm/very-low-birth-weight children. Pediatric Research. 2015;78(2):190. pmid:25927544

65. Hadders-Algra M, Huisjes H, Touwen B. Preterm or small-for-gestational-age infants. European Journal of Pediatrics. 1988;147(5):460–7. pmid:3409920

66. Heinonen K, Eriksson JG, Lahti J, Kajantie E, Pesonen A-K, Tuovinen S, et al. Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study. Pediatrics. 2015;135(4):818–25. pmid:25733746

67. Hirvonen M, Ojala R, Korhonen P, Haataja P, Eriksson K, Rantanen K, et al. Intellectual disability in children aged less than seven years born moderately and late preterm compared with very preterm and term‐born children–a nationwide birth cohort study. Journal of Intellectual Disability Research. 2017;61(11):1034–54. pmid:28699168

68. Holmström G, Larsson E. Long-term follow-up of visual functions in prematurely born children—a prospective population-based study up to 10 years of age. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2008;12(2):157–62. pmid:18083590

69. Huddy C, Johnson A, Hope P. Educational and behavioural problems in babies of 32–35 weeks gestation. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2001;85(1):F23–F8. pmid:11420317

70. Jurgens-Van der Zee A, Bierman-van Eendenburg M, Fidler V, Olinga A, Visch J, Touwen B, et al. Preterm birth, growth retardation and acidemia in relation to neurological abnormality of the newborn. Early Human Development. 1979;3(2):141–54. pmid:535545

71. Koç Ö, Kavuncuoğlu S, Ramoğlu MG, Aldemir E, Aktalay A, Eras Z. School performance and neurodevelopment of very low birth weight preterm infants: first report from Turkey. Journal of Child Neurology. 2016;31(2):170–6. pmid:26012506

72. Kuban KC, Joseph RM, O'shea TM, Allred EN, Heeren T, Douglass L, et al. Girls and boys born before 28 weeks gestation: risks of cognitive, behavioral, and neurologic outcomes at age 10 years. The Journal of Pediatrics. 2016;173:69–75. pmid:27004675

73. Lacey JL, PhD DJHSM. Assessment of preterm infants in the intensive‐care unit to predict cerebral palsy and motor outcome at 6 years. Developmental Medicine & Child Neurology. 1998;40(5):310–8.

74. Luu TM, Ment LR, Schneider KC, Katz KH, Allan WC, Vohr BR. Lasting effects of preterm birth and neonatal brain hemorrhage at 12 years of age. Pediatrics. 2009;123(3):1037–44. pmid:19255037

75. Talge NM, Holzman C, Wang J, Lucia V, Gardiner J, Breslau N. Late-preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age. Pediatrics. 2010;126(6):1124–31. pmid:21098151

76. Van Baar AL, Van Wassenaer AG, Briët JM, Dekker FW, Kok JH. Very preterm birth is associated with disabilities in multiple developmental domains. Journal of Pediatric Psychology. 2005;30(3):247–55. pmid:15784921

77. Van Nguyen T, Abe K. Pathogenesis of congenital rubella virus infection in human fetuses: viral infection in the ciliary body could play an important role in cataractogenesis. EBioMedicine. 2015;2(1):59–63. pmid:26137534

78. Allen KA, Brandon DH. Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments. Newborn and Infant Nursing Reviews. 2011;11(3):125–33. pmid:21927583

79. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549. pmid:21310794